Literature DB >> 31619554

Distinct Roles of Interferon Alpha and Beta in Controlling Chikungunya Virus Replication and Modulating Neutrophil-Mediated Inflammation.

Lindsey E Cook1, Marissa C Locke1, Alissa R Young2, Kristen Monte3, Matthew L Hedberg1, Raeann M Shimak1, Kathleen C F Sheehan1,4, Deborah J Veis1,3,5, Michael S Diamond1,2,3,4, Deborah J Lenschow6,3.   

Abstract

Type I interferons (IFNs) are key mediators of the innate immune response. Although members of this family of cytokines signal through a single shared receptor, biochemical and functional variation exists in response to different IFN subtypes. While previous work has demonstrated that type I IFNs are essential to control infection by chikungunya virus (CHIKV), a globally emerging alphavirus, the contributions of individual IFN subtypes remain undefined. To address this question, we evaluated CHIKV pathogenesis in mice lacking IFN-β (IFN-β knockout [IFN-β-KO] mice or mice treated with an IFN-β-blocking antibody) or IFN-α (IFN regulatory factor 7 knockout [IRF7-KO] mice or mice treated with a pan-IFN-α-blocking antibody). Mice lacking either IFN-α or IFN-β developed severe clinical disease following infection with CHIKV, with a marked increase in foot swelling compared to wild-type mice. Virological analysis revealed that mice lacking IFN-α sustained elevated infection in the infected ankle and in distant tissues. In contrast, IFN-β-KO mice displayed minimal differences in viral burdens within the ankle or at distal sites and instead had an altered cellular immune response. Mice lacking IFN-β had increased neutrophil infiltration into musculoskeletal tissues, and depletion of neutrophils in IFN-β-KO but not IRF7-KO mice mitigated musculoskeletal disease caused by CHIKV. Our findings suggest disparate roles for the IFN subtypes during CHIKV infection, with IFN-α limiting early viral replication and dissemination and IFN-β modulating neutrophil-mediated inflammation.IMPORTANCE Type I interferons (IFNs) possess a range of biological activity and protect against a number of viruses, including alphaviruses. Despite signaling through a shared receptor, there are established biochemical and functional differences among the IFN subtypes. The significance of our research is in demonstrating that IFN-α and IFN-β both have protective roles during acute chikungunya virus (CHIKV) infection but do so by distinct mechanisms. IFN-α limits CHIKV replication and dissemination, whereas IFN-β protects from CHIKV pathogenesis by limiting inflammation mediated by neutrophils. Our findings support the premise that the IFN subtypes have distinct biological activities in the antiviral response.
Copyright © 2019 American Society for Microbiology.

Entities:  

Keywords:  chikungunya virus; host-pathogen interactions; innate immunity; interferons

Mesh:

Substances:

Year:  2019        PMID: 31619554      PMCID: PMC6912113          DOI: 10.1128/JVI.00841-19

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  68 in total

1.  A mouse model of chikungunya virus-induced musculoskeletal inflammatory disease: evidence of arthritis, tenosynovitis, myositis, and persistence.

Authors:  Thomas E Morrison; Lauren Oko; Stephanie A Montgomery; Alan C Whitmore; Alina R Lotstein; Bronwyn M Gunn; Susan A Elmore; Mark T Heise
Journal:  Am J Pathol       Date:  2010-12-23       Impact factor: 4.307

2.  Direct triggering of the type I interferon system by virus infection: activation of a transcription factor complex containing IRF-3 and CBP/p300.

Authors:  M Yoneyama; W Suhara; Y Fukuhara; M Fukuda; E Nishida; T Fujita
Journal:  EMBO J       Date:  1998-02-16       Impact factor: 11.598

Review 3.  Lipid-cytokine-chemokine cascades orchestrate leukocyte recruitment in inflammation.

Authors:  Christian D Sadik; Andrew D Luster
Journal:  J Leukoc Biol       Date:  2011-11-04       Impact factor: 4.962

4.  Interferon regulatory factor IRF-7 induces the antiviral alpha interferon response and protects against lethal West Nile virus infection.

Authors:  Stephane Daffis; Melanie A Samuel; Mehul S Suthar; Brian C Keller; Michael Gale; Michael S Diamond
Journal:  J Virol       Date:  2008-06-18       Impact factor: 5.103

5.  Type I IFN controls chikungunya virus via its action on nonhematopoietic cells.

Authors:  Clémentine Schilte; Thérèse Couderc; Fabrice Chretien; Marion Sourisseau; Nicolas Gangneux; Florence Guivel-Benhassine; Anton Kraxner; Jürg Tschopp; Stephen Higgs; Alain Michault; Fernando Arenzana-Seisdedos; Marco Colonna; Lucie Peduto; Olivier Schwartz; Marc Lecuit; Matthew L Albert
Journal:  J Exp Med       Date:  2010-02-01       Impact factor: 14.307

Review 6.  Arthritogenic alphaviruses--an overview.

Authors:  Andreas Suhrbier; Marie-Christine Jaffar-Bandjee; Philippe Gasque
Journal:  Nat Rev Rheumatol       Date:  2012-05-08       Impact factor: 20.543

Review 7.  Reemergence of chikungunya virus.

Authors:  Thomas E Morrison
Journal:  J Virol       Date:  2014-07-30       Impact factor: 5.103

8.  Structural linkage between ligand discrimination and receptor activation by type I interferons.

Authors:  Christoph Thomas; Ignacio Moraga; Doron Levin; Peter O Krutzik; Yulia Podoplelova; Angelica Trejo; Choongho Lee; Ganit Yarden; Susan E Vleck; Jeffrey S Glenn; Garry P Nolan; Jacob Piehler; Gideon Schreiber; K Christopher Garcia
Journal:  Cell       Date:  2011-08-19       Impact factor: 41.582

9.  Selective Blockade of Interferon-α and -β Reveals Their Non-Redundant Functions in a Mouse Model of West Nile Virus Infection.

Authors:  Kathleen C F Sheehan; Helen M Lazear; Michael S Diamond; Robert D Schreiber
Journal:  PLoS One       Date:  2015-05-26       Impact factor: 3.240

10.  Inflammatory monocytes mediate control of acute alphavirus infection in mice.

Authors:  Kelsey C Haist; Kristina S Burrack; Bennett J Davenport; Thomas E Morrison
Journal:  PLoS Pathog       Date:  2017-12-15       Impact factor: 6.823

View more
  16 in total

1.  The Intestinal Microbiome Restricts Alphavirus Infection and Dissemination through a Bile Acid-Type I IFN Signaling Axis.

Authors:  Emma S Winkler; Swathi Shrihari; Barry L Hykes; Scott A Handley; Prabhakar S Andhey; Yan-Jang S Huang; Amanda Swain; Lindsay Droit; Kranthi K Chebrolu; Matthias Mack; Dana L Vanlandingham; Larissa B Thackray; Marina Cella; Marco Colonna; Maxim N Artyomov; Thaddeus S Stappenbeck; Michael S Diamond
Journal:  Cell       Date:  2020-07-14       Impact factor: 41.582

2.  Interferon Alpha, but Not Interferon Beta, Acts Early To Control Chronic Chikungunya Virus Pathogenesis.

Authors:  Marissa C Locke; Lindsey E Fox; Bria F Dunlap; Alissa R Young; Kristen Monte; Deborah J Lenschow
Journal:  J Virol       Date:  2021-10-20       Impact factor: 6.549

3.  A cross-reactive antibody protects against Ross River virus musculoskeletal disease despite rapid neutralization escape in mice.

Authors:  Julie M Fox; Ling Huang; Stephen Tahan; Laura A Powell; James E Crowe; David Wang; Michael S Diamond
Journal:  PLoS Pathog       Date:  2020-08-06       Impact factor: 6.823

Review 4.  Type I Interferon-Mediated Regulation of Antiviral Capabilities of Neutrophils.

Authors:  Ashley A Stegelmeier; Maedeh Darzianiazizi; Kiersten Hanada; Shayan Sharif; Sarah K Wootton; Byram W Bridle; Khalil Karimi
Journal:  Int J Mol Sci       Date:  2021-04-29       Impact factor: 5.923

Review 5.  Context Is Key: Delineating the Unique Functions of IFNα and IFNβ in Disease.

Authors:  Lindsey E Fox; Marissa C Locke; Deborah J Lenschow
Journal:  Front Immunol       Date:  2020-12-21       Impact factor: 7.561

6.  Interleukin-17A Facilitates Chikungunya Virus Infection by Inhibiting IFN-α2 Expression.

Authors:  Biswas Neupane; Dhiraj Acharya; Farzana Nazneen; Gabriel Gonzalez-Fernandez; Alex Sutton Flynt; Fengwei Bai
Journal:  Front Immunol       Date:  2020-11-16       Impact factor: 7.561

Review 7.  Complex Roles of Neutrophils during Arboviral Infections.

Authors:  Abenaya Muralidharan; St Patrick Reid
Journal:  Cells       Date:  2021-05-26       Impact factor: 6.600

8.  A SARS-CoV-2 Infection Model in Mice Demonstrates Protection by Neutralizing Antibodies.

Authors:  Ahmed O Hassan; James Brett Case; Emma S Winkler; Larissa B Thackray; Natasha M Kafai; Adam L Bailey; Broc T McCune; Julie M Fox; Rita E Chen; Wafaa B Alsoussi; Jackson S Turner; Aaron J Schmitz; Tingting Lei; Swathi Shrihari; Shamus P Keeler; Daved H Fremont; Suellen Greco; Paul B McCray; Stanley Perlman; Michael J Holtzman; Ali H Ellebedy; Michael S Diamond
Journal:  Cell       Date:  2020-06-10       Impact factor: 66.850

9.  Evolutionary Pattern of Interferon Alpha Genes in Bovidae and Genetic Diversity of IFNAA in the Bovine Genome.

Authors:  Sunday O Peters; Tanveer Hussain; Adeyemi S Adenaike; Jordan Hazzard; Olanrewaju B Morenikeji; Marcos De Donato; Sujay Paul; Masroor Babar; Abdulmojeed Yakubu; Ikhide G Imumorin
Journal:  Front Immunol       Date:  2020-09-30       Impact factor: 7.561

10.  SARS-CoV-2 infection of human ACE2-transgenic mice causes severe lung inflammation and impaired function.

Authors:  Emma S Winkler; Adam L Bailey; Natasha M Kafai; Sharmila Nair; Broc T McCune; Jinsheng Yu; Julie M Fox; Rita E Chen; James T Earnest; Shamus P Keeler; Jon H Ritter; Liang-I Kang; Sarah Dort; Annette Robichaud; Richard Head; Michael J Holtzman; Michael S Diamond
Journal:  Nat Immunol       Date:  2020-08-24       Impact factor: 31.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.